Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor

Oral Diseases

Volumn 15, Issue 7, 2009, Pages 472-477

  Ribeiro, B F ^a   Iglesias, D P P ^a   Nascimento, G J F ^a   Galvao H C ^a   Medeiros, A M C ^a   Freitas, R A ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Ameloblastoma; Extracellular matrix; Matrix metalloproteinases; Odontogenic adenomatoid tumor

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE;

AMELOBLASTOMA; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ODONTOGENIC TUMOR; PARENCHYMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA; STROMA CELL;

AMELOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; ODONTOGENIC TUMORS;

EID: 70349086896     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01575.x     Document Type: Article

References (25)

1. Barboza CAG, Pinto LP, Freitas RA, Costa ALL, Souza LB (2005). Proliferation cell nuclear antigen (PCNA) and p53 proteins expression in ameloblastoma and adenomatoid odontogenic tumor. Braz Dent J 16 : 56 61.
2. Barnes L, Eveson JW, Reichart PA, Sidransky D (2005). World Health Organization classification of tumours - pathology and genetics of head and neck tumours. Lyon : IarcPress.
3. Cotrim P, Andrade CR, Line S, Almeida OP, Coletta RD (2002). Expression and activity of matrix metalloproteinase-2 (MMP-2) in the development of rat first molar tooth germ. Braz Dent J 13 : 97 102.
4. Ikebe T, Shinohara M, Takeuchi H et al (1999). Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metastasis 17 : 315 323.
5. Kumamoto H, Ooya K (2006). Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatóide odontogenic tumors. Oral Dis 12 : 163 170.
6. Kumamoto H, Yamauchi K, Yoshida M, Ooya K (2003). Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 32 : 114 120.
7. Leon JE, Mata GM, Fregnani ER et al (2005). Clinicopathological and immunohistochemical study of 39 cases of adenomatoid odontogenic tumour: a multicentric study. Oral Oncol 41 : 835 842.
8. Medeiros AMC (2001). Expressão da fibronectina, tenascina e colágeno I em ameloblastoma e no tumor odontogênico adenomatóide. Tese (Doutorado em Patologia Oral) - Faculdade de Odontologia, Universidade Federal do Rio Grande do Norte : Natal. 125f.
9. Meer S, Galpin JS, Altini M, Coleman H, Ali H (2003). Proliferation cell nuclear antigen and Ki67 in ameloblastomas. Oral Surg Oral Med Or al Pathol Oral Radiol Endod 95 : 213 221.
10. Mott JD, Werb Z (2004). Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 : 558 564.
11. Murata M, Cheng J, Horino K, Hara K, Shimokawa H, Saku T (2000). Enamel proteins and extracellular matrix molecules are co-localized in the pseudocystic stromal space of adenomatoid odontogenic tumor. J Oral Pathol Med 29 : 483 490.
12. Nagase H, Visse R, Murphy G (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 : 562 573.
13. Nagel H, Laskawi R, Wahlers A, Hemmerlein B (2004). Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology 44 : 222 231.
14. Neville BW, Damm DD, Allen CM, Bouquot JE (2004). Patologia oral and maxilofacial. 2 edição. Editora Guanabara Koogan : Rio de Janeiro.
15. Pereira ALA, Veras SSL, Silveira JD et al (2005). O papel das proteínas da matriz extracelular e das metaloproteinases em carcinomas de cabeça e pescoço: uma atualização bibliográfica. Rev Bras Otorrinolaringol 71 : 81 86.
16. Pinheiro JJV, Freitas VM, Moretti AIS, Jorge AG, Jaeger RG (2004). Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 45 : 65 72.
17. Raitz R, Martins MD, Araújo VC (2003). A study of the matrix in salivary gland tumors. J Oral Pathol Med 32 : 290 296.
18. Santana HF, Boraks G, Settanni CEP (2004). Contribuição ao estudo dos antígenos celulares PCNA e Ki67 em ameloblastomas. Rev Int Estomatol 1 : 127 132.
19. Sempere FJV, Martinez MJA, Sirera BV, Marco JB (2006). Follicular adenomatoid odontogenic tumor: immunohistochemical study. Med Oral Pathol Oral Cir Bucal 11 : E305 E308.
20. Silva MS, Freire EG, Anjos ED, Silva LCF (2004). Tumor odontogênico adenomatóide: relato de caso clínico. Rev Ci. Traumatol Buco-Maxilo-Fac 4 : 246 251.
21. Silveira EJD, Piva MR, Galvão HC, Souza LB, Freitas RA (2007). Participação das metaloproteinases da matriz na etiopatogenia dos cistos odontogênicos. J Bras Patol Med Lab 43 : 203 209.
22. Souza AP, Line SRP (2002). The biology of matrix metalloproteinases. Rev FOB 10 : 1 6.
23. Teronen O, Salo T, Konttinen YT et al (1995). Identification and characterization of gelatinases/type IV collagenases in jaw cysts. J Oral Pathol Med 24 : 78 84.
24. Tsujigiwa H, Nagatsuka H, Han PP et al (2005). Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma. Oral Oncol 41 : 843 850.
25. Verma RP, Hansch C (2007). Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 15 : 2223 2268.